Illumina is looking to improve global access strategies for their molecular diagnostic solutions in oncology, adult and pediatric genetic disease, and reproductive health, ensuring individuals and families worldwide can benefit from genomic insights.
Requirements
- Proven success in HEOR publications (e.g. value demonstration, HEOR, Patient Reported Outcomes) and evidence strategy supporting market access strategies in diagnostics and/or biopharma.
- Understanding of reimbursement systems, HTA processes, and payer decision-making across major markets.
- Experience with molecular diagnostics and precision medicine applications.
- Strong leadership, strategic thinking, and cross-functional collaboration skills.
- Excellent communication and stakeholder engagement capabilities.
- Ability to manage budgets, vendors, and consultants.
Responsibilities
- Collaborate with the numerous Illumina departments to ensure appropriate and timely integration of all relevant HEOR and payer evidence into clinical trials and regulatory filings to maximize the US, EU, and Asian/ Middle East/ Emerging Markets applications and submissions.
- Support global market access strategies for molecular diagnostic solutions including client and ecosystem facing partnerships and internal development processes.
- Ensure that appropriate global quantitative research and health economic modeling (both prospective and RWD-driven) are undertaken to develop an integrated global approach for maximizing launch positioning and sustained market access.
- Align with modeling and micro-costing resources and advise as the company expands this capability.
- Collaboratively develop and execute a comprehensive and compelling publication plan as a part of a multi-stakeholder targeted publication strategy to appropriately disseminate value messages and evidence.
- Partner with regional and country Teams to act to secure reimbursement and access in key markets, addressing diverse payer requirements and Health Technology Assessment processes.
- Aid in monitoring global policy trends, HTA requirements, and payer expectations related to molecular diagnostic testing to inform strategic planning and product development.
Other
- Bachelor’s degree required; advanced degree (GC, MBA, MPH, PhD, or related) preferred.
- 18+ years of experience in clinical setting, market access, reimbursement, and/or health economics, with a strong focus on molecular diagnostics with 10 years of Management.
- Passion for improving lives through access to genomic technologies.
- This role is not eligible for visa sponsorship.
- Illumina prohibits the use of generative artificial intelligence (AI) in the application and interview process.
